Questions? Call 800-624-6242
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Seeking Security: Pathogens, Open Access, and Genome Databases
3
Issues in the Control of Genome Information: From Discussions at the Committee’s Workshop
39
Stakeholders in the Debate over Release of Genome Data,
40
Domestic Interest Groups and Perspectives,
41
International Issues,
43
Categories of Genome Data,
44
Data from Bioterror Agents vs. Other Pathogens,
45
Data from Naturally Occurring vs. Genetically Engineered Pathogens,
45
Primary Genome Sequences vs. Annotations,
46
Microarray and Other Functional Genome Data,
46
Tools for Analyzing Genome Data,
47
Potential Data-Control Mechanisms,
47
Classify Some Data,
48
Withhold Some Data from Widespread Public Release,
48
Allow Unlimited Data Access but Require Registration,
49
Summary of Issues Related to Restricting Access to Genome Data,
50
4
Conclusions and Recommendations
52
Recommendation 1,
52
Current Polices Are Effective,
53
Effective Restriction of Genome Data Is Not Practical,
54
Pathogen Genome Sequences Are Not Uniquely Dangerous,
55
Recommendation 2,
57
Recommendation 3,
58
Recommendation 4,
62
Recommendation 5,
64
References
65
Appendixes
A
Statement of Task
69
B
Agenda
71
C
Participants
73
